account_balance
Investment manager · 13F filer · SEC CIK 1512848
NEA Management Company, LLC
Reported value$1.59Bas of Jun 30, 2026
Positions26 1 new, 1 sold out
Top 10 weight90%TRVI alone is 16%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TRVI
Trevi Therapeutics, Inc.
15.5%
MBX
MBX Biosciences, Inc.
12.6%
GLUE
Monte Rosa Therapeutics, Inc.
11.7%
CELC
Celcuity Inc.
11.3%Trimmed
SGP
Spyglass Pharma, Inc.
10.4%
SVRA
Savara, Inc.
9.5%
ZBIO
Zenas BioPharma, Inc.
6.4%
COUR
Coursera, Inc.
4.6%
AUPH
Aurinia Pharmaceuticals, Inc.
4.2%
CRSP
CRISPR Therapeutics AG
3.6%
16 others
10.2%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed